Strength
600 mg/1
Manufacturer
Strides Pharma Inc.NDC
64380018901
Classification
Generic
Dosage Form
TABLET, MULTILAYER, EXTENDED RELEASE
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
ZILEUTONApproval Type
Generic (ANDA)
FDA Application
ANDA212670On Market Since
10/15/2022
Pharmacological Classes
5-Lipoxygenase Inhibitor
5-Lipoxygenase Inhibitors
Decreased Leukotriene Production
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.